Investors are generally searching for a stock market strategy that not only maximizes returns, but helps them build a portfolio that is set up to achieve long lasting success. New investors may find themselves overwhelmed by the day to day workings of the market. Understanding that markets are volatile and will sometimes be down for extended periods is just another part of the investing process. Having the proper stock portfolio diversification can be a big help when trying to combat volatile markets.

The Awesome Oscillator reading is currently -1.17658529 for Coherus BioSciences, Inc. (NASDAQ:CHRS). Technical traders will watch the AO especially when it crosses above or below the zero line. A move above the line may signal a bullish scenario. A move below the zero line may indicate a bearish selling opportunity. The AO may prove to be a valuable tool for many momentum traders.

Traders will take note of the 20 day Chaikin Money Flow indicator that is now at -0.01181325 on shares of Coherus BioSciences, Inc. (NASDAQ:CHRS). The value of this indicator will fluctuate between 1 and -1. Traders may be watching when the CMF crosses zero. This cross might point to a bullish or bearish price reversal depending on which way it is moving crossing the zero line.

Taking a look at the Donchian Channels indicator, we note that the 20 day lower band is 18.87. The 20 day upper band is 22.71. This indicator was created by Richard Donchian, and traders follow these channels to help identify potential trading signals.

Technical traders have many tools at their disposal when conducting stock research. One of those tools is the Exponential Moving Average or EMA. The EMA is similar to the simple moving average, but more weight is put on the newest data. Let’s look at some different EMA levels:

10 day Exponential Moving Average: 20.25461408
20 day Exponential Moving Average: 20.56129268
30 day Exponential Moving Average: 20.62109774
50 day Exponential Moving Average: 20.45491201
100 day Exponential Moving Average: 19.91584628
200 day Exponential Moving Average: 18.81191545

Following trading action on shares of Coherus BioSciences, Inc. (NASDAQ:CHRS), we see that the stock has moved 0.24 since the opening price of 20.02. So far, the stock has reached a high of 20.49 and dipped to a low of 19.84. The consensus rating on the stock is currently Sell, and today’s volume has been measured around 206275.

There are a number of different pivot points that traders can use when conducting stock analysis. Pivot points can be useful for traders looking to establish trading entry and exit points. Focusing on some popular one month pivots, we see that the Woodie pivot is currently at 21.0475. The Woodie support 1 pivot is 19.385, and the Woodie resistance 1 pivot is 21.675. The Camarilla one month pivot is presently 21.19666667. The one month Classic pivot is 21.19666667 and the Classic resistance 1 is 21.97333333 while the Classic support 1 pivot is measured at 19.68333333.

Tracking some stock ratings, we can see that the stock’s Moving Average Rating is currently pointing to a “Neutral”. Traders may be monitoring many different indicators in order to get a grasp of where the stock may be moving in the near future. Taking a look at the Oscillators rating, we note that the reading is pointing to a “Sell”.

When setting up a personal stock investment strategy, individual investors often set short-term and long-term goals. These goals may address the questions of specific objectives, how to start achieving these objectives, and the amount of risk that the individual is comfortable taking on. Once goals are in place, the investor can start to think about the overall strategy, and how they are going to start building the portfolio. A large number of investors will not reach their goals that they created at the outset. There may be many different reasons for this, but getting caught up in the excitement and chasing performance may be near the top of the list. Investors who figure out how to focus on the right information are typically more prepared for the numerous challenges that arise when dealing with the equity market.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.